Live attenuated influenza vaccine (Fluenz Tetra): patient group direction (PGD) template
PGD template to support the administration of live attenuated influenza vaccine (Fluenz Tetra) in accordance with the national seasonal influenza vaccination programme.
Applies to England
Documents
Details
This PGD template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Tetra) as part of the national seasonal influenza vaccination programme.
LAIV PGD version 13.00 is valid from 1 September 2023 to 1 April 2024.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Last updated 19 July 2023 + show all updates
-
Added version 13, see change history on page 3.
-
Updated footer on page one.
-
Added version 11, see change history on page 2.
-
Added updated PGD (V10.00).
-
Updated PGD template for the 2020 to 2021 flu season.
-
Updated PGD template for the 2019 to 2020 flu season.
-
Updated PGD template for the 2018 to 2019 flu season.
-
Child Health Information System (CHIS) recording requirement removed.
-
Updated PGD template for the 2017 to 2018 influenza season.
-
Updated PGD template for the 2016 to 2017 flu season.
-
Updated PGD to allow the provision of both presentations of live attenuated influenza vaccine which will be supplied for the 2015/16 season.
-
First published.